Delivery Order SPE2DB24D2101-SPE2DB25FKMSW
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,048.20 on July 23, 2025, for the supply of Dotarem 10 mmol/20 mL vials. The contract is competitively awarded without set-aside designation and carries a firm fixed price structure with an ultimate completion date of July 24, 2025. This award is funded by the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency responsible for pharmaceutical and medical...
- This is a $1,352.60 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of DOTAREM 10 MMOL/20 ML SYRINGE 20ML, a medical product used in healthcare. The contract has an ultimate completion date of April 7, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of DOTAREM 10 MMOL/20 ML VIAL 20ML, a specialty medication, with a ceiling value of $4,572.30 and a period of performance through January 13, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of DOTAREM 10 MMOL/20 ML VIAL 20ML medical supplies. The award, valued at $5,228.76, was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. This appears to be a Firm Fixed Price Delivery Order placed under a larger Indefinite Delivery Contract (IDC) with Amerisourcebergen, valued at $999,999,999 and expiring in...
- AmerisourceBergen Drug Corp, a leading pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $11,404.40 by the Defense Logistics Agency's Medical Supply Chain on July 21, 2025. The contract is structured as a firm fixed price delivery order with an ultimate completion date of July 22, 2025, and represents a non-competitive award under an existing indefinite delivery contract vehicle. This delivery order is a child contract under...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $31,825.80 on July 21, 2025, under a Firm Fixed Price contract with the Defense Logistics Agency's Medical Supply Chain. The delivery order, which has an ultimate completion date of July 22, 2025, was competitively awarded with no set-aside designation. This award represents a child contract issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $10,567.60 to AmerisourceBergen Drug Corp on July 28, 2025, with an ultimate completion date of the same day. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award was not set-aside and was competitively awarded, reflecting...
- This federal contract award, valued at $11,166.78, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Dotarem, a contrast agent used in medical imaging procedures, with a completion date of October 30, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $5,575.92 to AmerisourceBergen Drug Corp on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed price, competitively awarded delivery order was issued under a non-set-aside procurement to the pharmaceutical distributor's Corporate Office division, based in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's broader...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $44,648.74 by the Defense Logistics Agency's Medical Supply Chain on July 21, 2025, with an ultimate completion date of July 22, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is classified as a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKMSWDelivery Order
The Defense Logistics Agency awarded a $1,583.17 delivery order to AmerisourceBergen Drug Corp for DOTAREM 10 MMOL/20 ML vials on July 24, 2025, with an ultimate completion date of July 25, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded through an open procurement process. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical federal medical procurement vendor, particularly for military and veteran healthcare systems. The company's SPE2DX prime contract functions as a comprehensive global pharmaceutical support vehicle enabling the supply of medications, vaccines, syringes, vials, and test kits across multiple therapeutic domains to support military healthcare programs worldwide. Through this contract vehicle, AmerisourceBergen serves customers including the Defense Health Agency and U.S. Coast Guard. The DLA is planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen among the key contractors supporting federal healthcare procurement strategies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 7/24/25 |